To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene C19orf40TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
93 supporting clones for gene C19orf40 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
TI_57176172   .a 1 to 822 62 to 899 Q131X L132V V133G Q134S E135R ... tiling clone,   838/911
(91 %)
36 diff
(96.1 %id)
BI829252 brain, medulla .a 5 to 748 1 to 753       753/846
(89 %)
26 diff
(97.0 %id)
NM_152266.3   .a 30 to 1153 1 to 1124 exact RefSeq, AAA Possibly primed on the genome, locally A rich (30/34 A in genome downstream of last aligned base) 1124/1124
(100 %)
0 diff
(100 %id)
DA006539   .a 31 to 580 2 to 551   capped   550/550
(100 %)
1 diff
(99.9 %id)
BG708918 brain, hypothalamus .a 36 to 797 1 to 761 V198G V199G G200R Q201T F210S ...     761/761
(100 %)
11 diff
(98.6 %id)
BX376697 Neuroblastoma Cot 50-normalized .a 37 to 1049 1 to 1003 N189Y tiling clone, AAA   1003/1082
(92 %)
14 diff
(98.8 %id)
AK128668 uterus .a 38 to 2335 1 to 2301 exact tiling clone, available from FLJ,   2301/2301
(100 %)
8 diff
(99.7 %id)
DB259639 uterus .a 39 to 592 2 to 555   capped   554/554
(100 %)
1 diff
(99.9 %id)
DB491421 hypothalamus .a 41 to 388 1 to 347       347/364
(95 %)
8 diff
(97.9 %id)
BG418961 Kidney, renal cell adenocarcinoma .a 45 to 809 1 to 751 M114N V115G L116A L117A P118S ...     751/963
(77 %)
18 diff
(98.2 %id)
AL705725 human skeletal muscle .a 47 to 667 1 to 621       621/621
(100 %)
8 diff
(98.8 %id)
BX280853 melanotic melanoma, skin .a 48 to 518 18 to 488       471/488
(96 %)
6 diff
(98.8 %id)
BM452862 melanotic melanoma, skin .a 48 to 855 30 to 850 A209G F210L F211L T212H Q213A ...     821/851
(96 %)
20 diff
(97.7 %id)
DN990858 brain, whole brain .a 48 to 613 9 to 574       566/574
(98 %)
7 diff
(98.8 %id)
BG773468 testis .a 49 to 732 1 to 685       685/685
(100 %)
8 diff
(98.9 %id)
DB449124 testis .a 50 to 470 1 to 422       422/422
(100 %)
11 diff
(97.4 %id)
BG475301 melanotic melanoma, skin .a 56 to 953 1 to 899 L16M I88M V89*     899/899
(100 %)
40 diff
(95.6 %id)
BC020247 Skin, melanotic melanoma. .a 57 to 1153 1 to 1097 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (30/34 A in genome downstream of last aligned base) 1097/1097
(100 %)
6 diff
(99.5 %id)
BE394126 endometrium, adenocarcinoma cell line, uterus .a 65 to 701 1 to 638       638/638
(100 %)
4 diff
(99.4 %id)
BE275244 melanotic melanoma, skin .a 75 to 595 1 to 533       533/533
(100 %)
16 diff
(97.0 %id)
BC010170 Uterus, endometrium adenocarcinoma .a 77 to 1153 1 to 1077 exact available from MGC, AAA Possibly primed on the genome, locally A rich (30/34 A in genome downstream of last aligned base) 1077/1077
(100 %)
3 diff
(99.8 %id)
BI192542 epithelioid carcinoma cell line, Pancreas .a 77 to 887 1 to 831 E23D K24E W25M R26A G27L ...     831/896
(92 %)
57 diff
(93.7 %id)
BF028891 bladder, carcinoma, cell line .a 81 to 749 1 to 663       665/845
(78 %)
28 diff
(96.7 %id)
BG474464 eye, retinoblastoma .a 83 to 700 1 to 618       618/618
(100 %)
3 diff
(99.6 %id)
BC003535 Uterus, endometrium adenocarcinoma .a 85 to 1153 1 to 1069 exact available from MGC, AAA Possibly primed on the genome, locally A rich (30/34 A in genome downstream of last aligned base) 1069/1069
(100 %)
3 diff
(99.8 %id)
BE379434 endometrium, adenocarcinoma cell line, uterus .a 85 to 984 34 to 945 Q206A I207D H208P A209C F210L ...     912/973
(93 %)
30 diff
(97.0 %id)
BE790609 lung, small cell carcinoma .a 86 to 929 1 to 843 G200R Q201T A202S V203S A204G ...     843/913
(92 %)
28 diff
(97.0 %id)
BE793971 lung, small cell carcinoma .a 87 to 871 1 to 780 P182Q S183A I184S Q185S Q186N ...     780/975
(80 %)
14 diff
(98.6 %id)
DN831276 pooled .a 88 to 382 295 to 1     Submitted on the opposite strand 295/295
(100 %)
3 diff
(99.0 %id)
DN930519 pooled .a 89 to 418 330 to 1     Submitted on the opposite strand 330/330
(100 %)
2 diff
(99.4 %id)
BE396092 endometrium, adenocarcinoma cell line, uterus .a 96 to 749 1 to 648       648/766
(84 %)
12 diff
(98.5 %id)
BY994638   .a 97 to 758 29 to 690       662/690
(95 %)
6 diff
(99.2 %id)
BF036840 adenocarcinoma, ovary .a 100 to 748 1 to 649       649/649
(100 %)
1 diff
(99.9 %id)
DA697836   .a 124 to 681 2 to 561   capped   560/560
(100 %)
3 diff
(99.5 %id)
TI_813709145   .a 130 to 493 19 to 380       362/384
(94 %)
9 diff
(97.7 %id)
DN930518 pooled .a 147 to 490 1 to 344       344/344
(100 %)
7 diff
(98.0 %id)
TI_1948084346   .a 147 to 545 129 to 528       400/1191
(33 %)
13 diff
(99.0 %id)
TI_1948084348   .a 147 to 794 776 to 129       648/1464
(44 %)
6 diff
(99.6 %id)
TI_1948084900   .a 147 to 678 127 to 664       538/1170
(45 %)
30 diff
(97.5 %id)
TI_1948224474   .a 147 to 637 125 to 615       491/518
(94 %)
7 diff
(98.7 %id)
TI_1948224475   .a 147 to 789 129 to 772       644/1239
(51 %)
13 diff
(99.0 %id)
TI_1948224782   .a 147 to 669 144 to 669       526/1421
(37 %)
45 diff
(96.9 %id)
TI_1948225106   .a 147 to 651 127 to 631       505/531
(95 %)
7 diff
(98.7 %id)
TI_1948225107   .a 147 to 762 128 to 750       623/1317
(47 %)
23 diff
(98.3 %id)
TI_1948225426   .a 147 to 794 129 to 776       648/681
(95 %)
11 diff
(98.4 %id)
TI_1948225427   .a 147 to 794 127 to 776       650/1221
(53 %)
17 diff
(98.7 %id)
CV029182 mixed .a 148 to 783 1 to 636       636/636
(100 %)
2 diff
(99.7 %id)
EL735943 mixed .a 148 to 773 1 to 626       626/626
(100 %)
1 diff
(99.9 %id)
TI_1948084076   .a 149 to 794 778 to 127       652/1357
(48 %)
26 diff
(98.1 %id)
TI_1948084347   .a 150 to 790 133 to 772       640/1351
(47 %)
21 diff
(98.5 %id)
TI_1948225429   .a 150 to 794 774 to 125       650/1402
(46 %)
11 diff
(99.3 %id)
TI_1948084349   .a 151 to 794 770 to 129       642/1129
(56 %)
10 diff
(99.2 %id)
TI_1948225428   .a 151 to 794 772 to 124       649/1343
(48 %)
25 diff
(98.2 %id)
TI_1948084624   .a 182 to 794 742 to 127       616/1144
(53 %)
31 diff
(97.3 %id)
TI_1948084903   .a 202 to 794 728 to 128       601/1124
(53 %)
22 diff
(98.1 %id)
DN831275 pooled .a 204 to 492 1 to 289       289/289
(100 %)
2 diff
(99.4 %id)
TI_1948224476   .a 212 to 794 710 to 129       582/1258
(46 %)
16 diff
(98.8 %id)
BF793189 adrenal cortex carcinoma, cell line, adrenal gland .a 215 to 993 1 to 783       783/913
(85 %)
17 diff
(98.2 %id)
TI_1948084902   .a 248 to 794 674 to 126       549/1380
(39 %)
26 diff
(98.2 %id)
TI_1948084077   .a 251 to 794 678 to 127       552/1158
(47 %)
20 diff
(98.3 %id)
BQ421060 epithelioid carcinoma, Pancreas .a 337 to 1183 1 to 861       861/861
(100 %)
23 diff
(97.4 %id)
BF541507 hypernephroma, Kidney .a 391 to 1053 2 to 655       654/876
(74 %)
13 diff
(98.6 %id)
TI_1948225109   .a 420 to 794 499 to 125       375/402
(93 %)
0 diff
(100 %id)
BF969106 adrenal cortex carcinoma, cell line, adrenal gland .a 427 to 1163 1 to 738   AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 738/740
(99 %)
10 diff
(98.7 %id)
BX390218 Neuroblastoma Cot 50-normalized .a 806 to 1706 9 to 910   tiling clone,   902/913
(98 %)
29 diff
(96.9 %id)
BM679170 eye, fetal eye .a 1159 to 1607 465 to 16   AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 450/450
(100 %)
1 diff
(99.8 %id)
CA419774 Bone, Human Chondrosarcoma Cell Line .a 1162 to 1607 462 to 16   AAA Possibly primed on the genome, locally A rich (21/22 A in genome downstream of last aligned base) 447/447
(100 %)
2 diff
(99.6 %id)
BF738754 bladder_tumor .a 1247 to 1732 1 to 490       490/492
(99 %)
23 diff
(95.4 %id)
AW403678 lymph .a 1281 to 1608 1 to 328       328/374
(87 %)
5 diff
(98.7 %id)
TI_154140453   .a 1288 to 1608 80 to 400       321/707
(45 %)
1 diff
(99.9 %id)
CV365391 bladder_tumor .a 1503 to 1640 19 to 154       136/154
(88 %)
6 diff
(96.2 %id)
DB351570 uterus .a 1822 to 2335 515 to 1   tiling clone,   515/515
(100 %)
1 diff
(99.9 %id)
BM761534 myeloma .a 1882 to 2351 1 to 472       472/472
(100 %)
3 diff
(99.4 %id)
BM782044 myeloma .a 1882 to 2445 1 to 566       566/566
(100 %)
5 diff
(99.2 %id)
BX329797 Neuroblastoma Cot 50-normalized .a 2032 to 2815 806 to 18   tiling clone,   789/901
(87 %)
0 diff
(100 %id)
BM761766 lymph node, stomach .a 2084 to 2517 1 to 433       433/433
(100 %)
8 diff
(98.2 %id)
BX281646 brain, hippocampus .a 2700 to 3163 22 to 485       464/485
(95 %)
6 diff
(98.8 %id)
AA468183   .a 2700 to 2926 33 to 258       226/258
(87 %)
9 diff
(96.6 %id)
BP421948 small intestine .a 2705 to 3180 480 to 5   tiling clone,   476/483
(98 %)
0 diff
(100 %id)
AW966734   .a 2707 to 3182 1 to 475       475/475
(100 %)
17 diff
(96.5 %id)
BQ429727 testis .a 2856 to 3432 1 to 585   tiling clone,   585/830
(70 %)
26 diff
(96.9 %id)
BG164300 hypernephroma, cell line, Kidney .b 1 to 681 1 to 677 Q189R I190F H191M A192P F193S ... tiling clone,   677/959
(70 %)
11 diff
(98.9 %id)
BG167873 hypernephroma, cell line, Kidney .b 75 to 820 1 to 731   tiling clone,   731/926
(78 %)
18 diff
(98.1 %id)
CD690094 normal nasopharynx .c 1 to 537 24 to 560   tiling clone,   537/560
(95 %)
7 diff
(98.8 %id)
BF185751 brain, glioblastoma .c 41 to 708 1 to 662       662/859
(77 %)
26 diff
(97.0 %id)
BU155119 melanotic melanoma, skin .c 69 to 822 12 to 767 exact tiling clone,   756/840
(90 %)
15 diff
(98.3 %id)
BF036603 adenocarcinoma, ovary .c 161 to 841 1 to 690 L23W V24W A25Q G26E N27M ... tiling clone,   690/874
(78 %)
37 diff
(95.8 %id)
BF675960 Prostate .d 1 to 609 1 to 599 G18W M19N V20G L21A L22A ... tiling clone,   599/871
(68 %)
20 diff
(97.8 %id)
CN368337 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 40 to 772 1 to 733 exact tiling clone,   733/733
(100 %)
3 diff
(99.6 %id)
CA307247 Alveolar Macrophage, lung Gene C19orf40, variant not shown       AAA Suspected internal deletion, this clone was ignored    
BX421628 T cells (Jurkat cell line) Gene C19orf40, variant not shown       AAA Suspected internal deletion, this clone was ignored    
AK309396 brain Gene C19orf40, variant not shown         This clone was ignored    
DC351324 brain Gene C19orf40, variant not shown         This clone was ignored    
BE563642 adenocarcinoma, Pancreas Gene C19orf40, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI